Cantitate/Preț
Produs

Genome and Proteome in Oncology

Editat de F. Tzortzatou Stathopoulou
en Limba Engleză Paperback – 31 mai 2005
The nature of cancer disease, its probable causes, and the molecular and cellular mechanisms through which malignant tumours develop, have only recently begun to be understood in any appreciable detail. Cancer is fundamentally a disease of the genome, arising from dynamic changes occurring within DNA during the lifetime of the cell e.g. deletions, amplifications, point mutations, translocations, that can occur in any cell and that may interact in a variety of cellular pathways. The imbalance in the interplay between genetic and environmental factors can initiate malignancy. The determination of the human genome sequence is acclaimed as one of the great achievements made possible by the rapid progress in the available molecular biology tools achieved during the last few years. The sequence of the human genome promises to unveil invaluable information useful for the development of novel approaches in the diagnosis and treatment of cancer disease. This book includes part of the work of international experts on the most up-to-date developments of various aspects of research on genome and proteome in oncology. The scientists suggest that the genetic key to human complexity lies not in the number of genes but in how gene parts are used to build different products in a process of the mRNA transcript called alternative splicing.
Citește tot Restrânge

Preț: 96826 lei

Preț vechi: 132084 lei
-27% Nou

Puncte Express: 1452

Preț estimativ în valută:
18531 19248$ 15392£

Carte disponibilă

Livrare economică 13-27 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781594542855
ISBN-10: 1594542856
Pagini: 359
Ilustrații: tables & charts
Dimensiuni: 187 x 265 x 29 mm
Greutate: 0.99 kg
Editura: Nova Science Publishers Inc

Cuprins

Preface; DNA and its Relationship to Cancer; Global Amplification of Sense RNA: A Novel Method to Replicate and Archive RNA for Cancer Biomarker Discovery and Validation; Genome Reviews and Proteome Analysis; Genomics and Proteomics in the Early Detection and Prevention of Cancer; Proteomic Analyses in Oncology; SELDI-TOF Profiling for Clinical Diagnostic Assay Development; Proteomic Techniques for Individualised Cancer Therapy; Proteomics in Breast Cancer; Application of Proteomics to Prostate Cancer Research; The Role of Proteomics Applications in Brain Tumour Biomarker Discovery; Tumour-associated Proteins in Chemically Induced Rat Hepatomas and their Analogous Proteins in ; Gene Expression Profiling and its Application for Characterisation of Mechanism(s) of Action of Anti-cancer Drugs, Molecular Classification and Prognostication in Hematologic Malignancies: Focus on Plasma Cell Dyscrasias; Proteomic Profiling Studies for Delineation of Mechanism(s) of Action of Anti-cancer Drugs, Molecular Classification and Prognostication of Human Malignancies: Focus on Multiple Myeloma and other Plasma Cell Dyscrasias; Biomarkers in Cancer Detection and Risk Assessment; Gene Expression Profile of Childhood Acute Lymphoblastic Leukaemia During Chemotherapy by cDNA Microarrays; Epstein-Barr virus Infection and Viral Gene Expression in Paediatric Non-Hodgkin Lymphomas; Genome and Proteome in Neuroblastoma; Index.